University Foundation of Health Sciences-FUCS, Hospital de San José. Bogota, Colombia.
Fundación Universitaria de Ciencias de la Salud-FUCS, Hospital de San José. Bogota, Colombia.
J Craniofac Surg. 2024 Jun 1;35(4):1177-1180. doi: 10.1097/SCS.0000000000010099. Epub 2024 Apr 3.
Fibrous dysplasia is a disorder in which normal bone is gradually replaced by immature fibro-osseous tissue, with an incidence of less than 7% of all benign bone tumors. The management of this disease is a challenge for plastic surgeons and neurosurgeons.
To describe the diagnostic, therapeutic, and outcome approach of patients with craniofacial fibrous dysplasia seen at the Plastic Surgery Service of the Hospital San José in Bogotá, Colombia.
This is a descriptive and retrospective case series study of patients diagnosed with monostotic and polyostotic fibrous dysplasia treated at the Plastic Surgery Department of Hospital San José during the period from January 1, 2010, to July 31, 2023.
All (n=10) of the patients had monostotic craniofacial fibrous dysplasia. The most affected bones in patients with monostotic fibrous dysplasia were zone I bones (n=10, 100%), followed by zone II bones (n=2, 20%). Patients with zone I and II involvement manifested throbbing headaches associated with phosphenes and tinnitus (n=8, 80%) and pain during occlusion associated with edema in the affected cheek (n=5, 50%). Physical examination showed that patients with orbital wall involvement (zone I bone) had ocular dystopia (n=7, 70%).Regarding the treatment received by the patients, 90% (n=9) of the patients received surgical management as primary treatment, with orbitotomy, replacement, and/or remodeling of the roof and lateral wall of the orbit with bone graft, drilling, canthoplasty, ciliary suspension being the most frequently performed procedure (n=6, 60%). Of the patients, 20% (n=2) required reintervention.
FD is a slowly progressive benign fibro-osseous disease that requires a timely, individualized, and multidisciplinary diagnosis and treatment to obtain favorable clinical and surgical results.The mainstay of treatment is surgery as a preventive measure since it is important to avoid future functional alterations that, depending on the location of the dysplasia, would cause a high risk of alteration of adjacent structures.
纤维结构不良是一种疾病,其中正常骨逐渐被不成熟的纤维骨组织取代,其发病率低于所有良性骨肿瘤的 7%。这种疾病的治疗对整形外科医生和神经外科医生来说是一个挑战。
描述在哥伦比亚波哥大圣何塞医院整形外科就诊的颅面纤维结构不良患者的诊断、治疗和预后方法。
这是一项对 2010 年 1 月 1 日至 2023 年 7 月 31 日期间在圣何塞医院整形外科接受治疗的单发性和多发性纤维结构不良患者进行的描述性和回顾性病例系列研究。
所有(n=10)患者均患有单发性颅面纤维结构不良。在患有单发性纤维结构不良的患者中,最受影响的骨骼是 I 区骨骼(n=10,100%),其次是 II 区骨骼(n=2,20%)。I 区和 II 区受累的患者表现为与闪光和耳鸣相关的搏动性头痛(n=8,80%)和与受累脸颊水肿相关的咬合时疼痛(n=5,50%)。体格检查显示眼眶壁受累(I 区骨骼)的患者存在眼球偏位(n=7,70%)。关于患者接受的治疗,90%(n=9)的患者接受了手术治疗作为主要治疗方法,最常进行的手术包括眶切开术、置换术和/或重塑眶顶和外侧壁,使用骨移植物、钻孔、canthoplasty、睫状悬带(n=6,60%)。其中,20%(n=2)的患者需要再次干预。
FD 是一种缓慢进展的良性纤维骨疾病,需要及时、个体化和多学科的诊断和治疗,以获得良好的临床和手术结果。治疗的主要方法是手术,因为预防很重要,因为避免未来的功能改变很重要,因为根据病变的位置,会导致相邻结构改变的高风险。